These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 34225791)

  • 1. Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.
    Chen M; Yuan Y; Zhou Y; Deng Z; Zhao J; Feng F; Zou H; Sun C
    Infect Dis Poverty; 2021 Jul; 10(1):94. PubMed ID: 34225791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
    Sharif N; Alzahrani KJ; Ahmed SN; Dey SK
    Front Immunol; 2021; 12():714170. PubMed ID: 34707602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis.
    Du Y; Chen L; Shi Y
    Front Public Health; 2022; 10():829176. PubMed ID: 35493393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events following COVID-19 vaccination: A systematic review and meta-analysis.
    Kouhpayeh H; Ansari H
    Int Immunopharmacol; 2022 Aug; 109():108906. PubMed ID: 35671640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021.
    Glover C; Deng L; Larter C; Brogan C; Richardson O; Huang YA; Kay E; Macartney K; Wood N
    Commun Dis Intell (2018); 2024 Jun; 48():. PubMed ID: 38926650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis.
    Li Z; Liu S; Li F; Li Y; Li Y; Peng P; Li S; He L; Liu T
    Front Immunol; 2022; 13():965971. PubMed ID: 36177017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events following immunization of COVID-19 vaccine among children aged 6-11 years.
    Puspitarani F; Sitaresmi MN; Ahmad RA
    Front Public Health; 2022; 10():999354. PubMed ID: 36388348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials.
    Korang SK; von Rohden E; Veroniki AA; Ong G; Ngalamika O; Siddiqui F; Juul S; Nielsen EE; Feinberg JB; Petersen JJ; Legart C; Kokogho A; Maagaard M; Klingenberg S; Thabane L; Bardach A; Ciapponi A; Thomsen AR; Jakobsen JC; Gluud C
    PLoS One; 2022; 17(1):e0260733. PubMed ID: 35061702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the safety profile of COVID-19 vaccines: a rapid review.
    Wu Q; Dudley MZ; Chen X; Bai X; Dong K; Zhuang T; Salmon D; Yu H
    BMC Med; 2021 Jul; 19(1):173. PubMed ID: 34315454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis.
    Wu X; Xu K; Zhan P; Liu H; Zhang F; Song Y; Lv T
    BMC Infect Dis; 2024 Feb; 24(1):234. PubMed ID: 38383356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis.
    Haas JW; Bender FL; Ballou S; Kelley JM; Wilhelm M; Miller FG; Rief W; Kaptchuk TJ
    JAMA Netw Open; 2022 Jan; 5(1):e2143955. PubMed ID: 35040967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of COVID-19 vaccines: A systematic review and meta-analysis of controlled and randomized clinical trials.
    Beladiya J; Kumar A; Vasava Y; Parmar K; Patel D; Patel S; Dholakia S; Sheth D; Boddu SHS; Patel C
    Rev Med Virol; 2024 Jan; 34(1):e2507. PubMed ID: 38282394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults.
    Xu K; Wang Z; Qin M; Gao Y; Luo N; Xie W; Zou Y; Wang J; Ma X
    Front Immunol; 2023; 14():1113156. PubMed ID: 36936964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term outcomes of cardiac adverse events following COVID-19 immunization managed in a Canadian pediatric center.
    Pham-Huy A; Bowes J; Russell K; Amira A; Lai L
    Vaccine; 2024 Oct; 42(24):126090. PubMed ID: 39003104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of COVID-19 vaccines in children and adolescents: A systematic review of randomized controlled trials.
    Tian F; Yang R; Chen Z
    J Med Virol; 2022 Oct; 94(10):4644-4653. PubMed ID: 35705969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of COVID-19 vaccines in patients with non-communicable diseases: a protocol for systematic review and meta-analysis of randomised controlled trials.
    Shi C; Wu M; Wang X; Yang K
    BMJ Open; 2022 May; 12(5):e057233. PubMed ID: 35613806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.